Europe Blood Plasma & Plasma Derived Medicinal Products Market
Description
Europe blood plasma & plasma derived medicinal Products market is expected to reach USD 13.75 billion by 2032 from USD 7.96 billion in 2024, growing at a CAGR of 7.11% during the forecast period of 2025 to 2032.
Market Segmentation:
Europe Blood Plasma & Plasma Derived Medicinal Products Market, By Product (Immunoglobulins, Coagulation Factors (For Bleeding Disorders), Albumin (Plasma Volume Expander), Protease Inhibitors (For Genetic Deficiencies), Monoclonal Antibodies (Derived From Plasma Cells), and Other Plasma Derived Proteins), Application (Immunology, Hematology, Critical Care, Neurology, Pulmonology, Haemato-Oncology, Rheumatology, and Other Applications), Processing Technology (Ion Exchange Chromatography, Affinity Chromatography, Cryoprecipitation, Ultrafiltration, and Microfiltration), Mode (Modern and Traditional Plasma Fractionation), End-User (Hospitals & Clinics, Research Labs, Academic Institutes, and Others), Distribution Channel (Direct Tender, Third Party Distributors, and Others), Country (Germany, France, U.K., Italy, Spain, Russia, Turkey, Netherlands, Switzerland, Poland, Denmark, Sweden, Belgium, Ireland, Norway, Finland, and Rest of Europe) - Industry Trends and Forecast to 2032
Overview of the Europe Blood Plasma & Plasma Derived Medicinal Market Dynamics:
Drivers
• Rising prevalence of rare and chronic diseases
• Expanding geriatric population
Restraints
• High cost and complex manufacturing process
• Lack of plasma supply and donor
Opportunities
• Advancements in plasma processing technologies to enhance yield and reduce costs
• Reimbursement frameworks and increased governmental focus on rare disease treatment
Market Players:
The key players operating in the Europe blood plasma & plasma derived medicinal products market are:
• CSL
• Takeda Pharmaceutical Company Limited
• Grifols, S.A.
• Octapharma AG
• Kedrion
• Bharat Serums
• Biotest AG
• Fresenius Kabi AG
• Intas Pharmaceuticals Ltd.
• Kamada Pharmaceuticals
• KM Biologics
• LFB
• Reliance Life Sciences
• SK Plasma
• Synthaverse S. A.
• VIRCHOW BIOTECH
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Market Segmentation:
Europe Blood Plasma & Plasma Derived Medicinal Products Market, By Product (Immunoglobulins, Coagulation Factors (For Bleeding Disorders), Albumin (Plasma Volume Expander), Protease Inhibitors (For Genetic Deficiencies), Monoclonal Antibodies (Derived From Plasma Cells), and Other Plasma Derived Proteins), Application (Immunology, Hematology, Critical Care, Neurology, Pulmonology, Haemato-Oncology, Rheumatology, and Other Applications), Processing Technology (Ion Exchange Chromatography, Affinity Chromatography, Cryoprecipitation, Ultrafiltration, and Microfiltration), Mode (Modern and Traditional Plasma Fractionation), End-User (Hospitals & Clinics, Research Labs, Academic Institutes, and Others), Distribution Channel (Direct Tender, Third Party Distributors, and Others), Country (Germany, France, U.K., Italy, Spain, Russia, Turkey, Netherlands, Switzerland, Poland, Denmark, Sweden, Belgium, Ireland, Norway, Finland, and Rest of Europe) - Industry Trends and Forecast to 2032
Overview of the Europe Blood Plasma & Plasma Derived Medicinal Market Dynamics:
Drivers
• Rising prevalence of rare and chronic diseases
• Expanding geriatric population
Restraints
• High cost and complex manufacturing process
• Lack of plasma supply and donor
Opportunities
• Advancements in plasma processing technologies to enhance yield and reduce costs
• Reimbursement frameworks and increased governmental focus on rare disease treatment
Market Players:
The key players operating in the Europe blood plasma & plasma derived medicinal products market are:
• CSL
• Takeda Pharmaceutical Company Limited
• Grifols, S.A.
• Octapharma AG
• Kedrion
• Bharat Serums
• Biotest AG
• Fresenius Kabi AG
• Intas Pharmaceuticals Ltd.
• Kamada Pharmaceuticals
• KM Biologics
• LFB
• Reliance Life Sciences
• SK Plasma
• Synthaverse S. A.
• VIRCHOW BIOTECH
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Table of Contents
350 Pages
- 1 Introduction
- 1.1 Objectives Of The Study
- 1.2 Market Definition
- 1.3 Overview Of The Europe Blood Plasma & Plasma Derived Medicinal Products Market
- 1.4 Limitations
- 1.5 Markets Covered
- 2 Market Segmentation
- 2.1 Markets Covered
- 2.2 Geographical Scope
- 2.3 Years Considered For The Study
- 2.4 Currency And Pricing
- 2.5 Dbmr Tripod Data Validation Model
- 2.6 Multivariate Modelling
- 2.7 Product Lifeline Curve
- 2.8 Primary Interviews With Key Opinion Leaders
- 2.9 Dbmr Market Position Grid
- 2.10 Market End User Coverage Grid
- 2.11 Vendor Share Analysis
- 2.12 Secondary Sources
- 2.13 Assumptions
- 3 Executive Summary
- 4 Premium Insights
- 4.1 Pestle Analysis
- 4.1.1 Political Factors
- 4.1.2 Economic Factors
- 4.1.3 Social Factors
- 4.1.4 Technological Factors
- 4.1.5 Environmental Factors
- 4.1.6 Legal Factors
- 4.2 Porter’s Five Forces
- 4.2.1 Threat Of New Entrants
- 4.2.2 Bargaining Power Of Suppliers
- 4.2.3 Bargaining Power Of Buyers
- 4.2.4 Threat Of Substitutes
- 4.2.5 Industry Rivalry
- 4.3 Supply Chain Impact On The Europe Blood Plasma & Plasma Derived Medicinal Products Market
- 4.3.1 Overview
- 4.3.2 Raw Material Availability
- 4.3.3 Manufacturing Capacity
- 4.3.4 Logistics And Last-mile Hurdles
- 4.3.5 Pricing Models And Market Positioning
- 4.4 Innovation Strategies
- 4.4.1 Key Innovation Strategies
- 4.4.2 Emerging Delivery Techniques
- 4.4.3 Strategic Implications
- 4.4.4 Conclusion
- 4.5 Risk And Mitigation
- 4.6 Vendor Selection Dynamics
- 4.6.1 Product Quality And Regulatory Compliance
- 4.6.2 Supply Chain Capabilities And Reliability
- 4.6.3 Clinical Efficacy And Innovation
- 4.6.4 Cost Competitiveness And Reimbursement Compatibility
- 4.6.5 Local Market Presence And Support Infrastructure
- 4.6.6 Ethical Sourcing, Esg Compliance, And Transparency
- 4.6.7 Conclusion
- 4.7 Tariffs And Their Impact On Market
- 4.7.1 Current Tariff Rates In Top-5 Country Markets
- 4.7.2 Outlook: Local Production V/S Import Reliance
- 4.7.3 Vendor Selection Criteria Dynamics
- 4.7.4 Impact On Supply Chain
- 4.7.5 Impact On Prices
- 4.7.6 Regulatory Inclination
- 4.7.6.1 Gcc Trade Alignment & Ftas
- 4.7.6.2 Special Zones And Re-export Models
- 4.7.6.3 Local Subsidy & Policy Response
- 4.7.6.4 Domestic Course Of Correction
- 5 Regulation Coverage
- 6 Market Overview
- 6.1 Drivers
- 6.1.1 Rising Prevalence Of Rare And Chronic Diseases
- 6.1.2 Expanding Geriatric Population
- 6.1.3 Technological Advancements In Plasma Fractionation
- 6.1.4 Government And Institutional Support
- 6.2 Restraints
- 6.2.1 High Cost And Complex Manufacturing Process
- 6.2.2 Lack Of Plasma Supply And Donor
- 6.3 Opportunities
- 6.3.1 Advancements In Plasma Processing Technologies To Enhance Yield And Reduce Costs
- 6.3.2 Reimbursement Frameworks And Increased Governmental Focus On Rare Disease Treatment
- 6.3.3 Strategic Alliances, Mergers, And Acquisitions To Strengthen Europe Market Penetration
- 6.4 Challenges
- 6.4.1 Competitive Pressure From Recombinant And Alternative Biological Therapies
- 6.4.2 Infrastructure Limitations In Cold Chain Logistics Impacting Product Distribution
- 7 Europe Blood Plasma & Plasma Derived Medicinal Products Market, By Product
- 7.1 Overview
- 7.2 Immunoglobulins
- 7.3 Coagulation Factors (For Bleeding Disorders)
- 7.4 Albumin (Plasma Volume Expander)
- 7.5 Protease Inhibitors (For Genetic Deficiencies)
- 7.6 Monoclonal Antibodies (Derived From Plasma Cells)
- 7.7 Other Plasma Derived Proteins
- 8 Europe Blood Plasma & Plasma Derived Medicinal Products Market, By Application
- 8.1 Overview
- 8.2 Immunology
- 8.3 Hematology
- 8.4 Critical Care
- 8.5 Neurology
- 8.6 Pulmonology
- 8.7 Haemato-oncology
- 8.8 Rheumatology
- 8.9 Other Applications
- 9 Europe Blood Plasma & Plasma Derived Medicinal Products Market, By Technology
- 9.1 Overview
- 9.2 Ion Exchange Chromatography
- 9.3 Affinity Chromatography
- 9.4 Cryoprecipitation
- 9.5 Ultrafiltration
- 9.6 Microfiltration
- 10 Europe Blood Plasma & Plasma Derived Medicinal Products Market, By Mode
- 10.1 Overview
- 10.2 Modern
- 10.3 Traditional Plasma Fractionation
- 11 Europe Blood Plasma & Plasma Derived Medicinal Products Market, By End User
- 11.1 Overview
- 11.2 Hospitals & Clinics
- 11.3 Research Labs
- 11.4 Academic Institutes
- 11.5 Others
- 12 Europe Blood Plasma & Plasma Derived Medicinal Products Market, By Distribution Channel
- 12.1 Overview
- 12.2 Direct Tenders
- 12.3 Third Party Distributors
- 12.4 Others
- 13 Europe Blood Plasma & Plasma Derived Medicinal Products Market, By Region
- 13.1 Europe
- 13.1.1 Germany
- 13.1.2 France
- 13.1.3 U.K
- 13.1.4 Italy
- 13.1.5 Spain
- 13.1.6 Russia
- 13.1.7 Turkey
- 13.1.8 Netherlands
- 13.1.9 Switzerland
- 13.1.10 Poland
- 13.1.11 Denmark
- 13.1.12 Sweden
- 13.1.13 Belgium
- 13.1.14 Ireland
- 13.1.15 Norway
- 13.1.16 Finland
- 13.1.17 Rest Of Europe
- 14 Europe Blood Plasma & Plasma Derived Medicinal Products Market, Company Landscape
- 14.1 Company Share Analysis: Europe
- 15 Swot Analysis
- 16 Company Profile
- 16.1 Csl
- 16.1.1 Company Snapshot
- 16.1.2 Revenue Analysis
- 16.1.3 Company Share Analysis
- 16.1.4 Product Portfolio
- 16.1.5 Recent Developments
- 16.2 Takeda Pharmaceutical Company Limited
- 16.2.1 Company Snapshot
- 16.2.2 Revenue Analysis
- 16.2.3 Company Share Analysis
- 16.2.4 Product Portfolio
- 16.2.5 Recent Developments
- 16.3 Grifols, S.A.
- 16.3.1 Company Snapshot
- 16.3.2 Revenue Analysis
- 16.3.3 Company Share Analysis
- 16.3.4 Product Portfolio
- 16.3.5 Recent Developments
- 16.4 Octapharma Ag
- 16.4.1 Company Snapshot
- 16.4.2 Company Share Analysis
- 16.4.3 Product Portfolio
- 16.4.4 Recent Developments
- 16.5 Kedrion
- 16.5.1 Company Snapshot
- 16.5.2 Company Share Analysis
- 16.5.3 Product Portfolio
- 16.5.4 Recent Development
- 16.6 Adma Biologics, Inc
- 16.6.1 Company Snapshot
- 16.6.2 Revenue Analysis
- 16.6.3 Product Portfolio
- 16.6.4 Recent Development
- 16.7 Aegros
- 16.7.1 Company Snapshot
- 16.7.2 Product Portfolio
- 16.7.3 Recent Development
- 16.8 Bharat Serums
- 16.8.1 Company Snapshot
- 16.8.2 Product Portfolio
- 16.8.3 Recent Development
- 16.9 Biotest Ag.
- 16.9.1 Company Snapshot
- 16.9.2 Revenue Analysis
- 16.9.3 Product Portfolio
- 16.9.4 Recent Developments
- 16.10 Fresenius Kabi Ag
- 16.10.1 Company Snapshot
- 16.10.2 Product Portfolio
- 16.10.3 Recent Development
- 16.11 Gc Biopharma Corporate
- 16.11.1 Company Snapshot
- 16.11.2 Revenue Analysis
- 16.11.3 Product Portfolio
- 16.11.4 Recent Development
- 16.12 Ichor
- 16.12.1 Company Snapshot
- 16.12.2 Product Portfolio
- 16.12.3 Recent Development
- 16.13 Intas Pharmaceuticals Ltd.
- 16.13.1 Company Snapshot
- 16.13.2 Product Portfolio
- 16.13.3 Recent Development
- 16.14 Kamada Pharmaceuticals
- 16.14.1 Company Snapshot
- 16.14.2 Revenue Analysis
- 16.14.3 Product Portfolio
- 16.14.4 Recent Development
- 16.15 Km Biologics
- 16.15.1 Company Snapshot
- 16.15.2 Product Portfolio
- 16.15.3 Recent Development
- 16.16 Lfb
- 16.16.1 Company Snapshot
- 16.16.2 Product Portfolio
- 16.16.3 Recent Development
- 16.17 Plasmagen Biosciences Pvt. Ltd.
- 16.17.1 Company Snapshot
- 16.17.2 Product Portfolio
- 16.17.3 Recent Developments
- 16.18 Proliant Health & Biologicals
- 16.18.1 Company Snapshot
- 16.18.2 Product Portfolio
- 16.18.3 Recent Development
- 16.19 Promea
- 16.19.1 Company Snapshot
- 16.19.2 Product Portfolio
- 16.19.3 Recent Development
- 16.20 Reliance Life Sciences
- 16.20.1 Company Snapshot
- 16.20.2 Business Portfolio
- 16.20.3 Recent Development
- 16.21 Sichuan Yuanda Shyuang Pharmaceutical Co., Ltd.
- 16.21.1 Company Snapshot
- 16.21.2 Product Portfolio
- 16.21.3 Recent Development
- 16.22 Sk Plasma
- 16.22.1 Company Snapshot
- 16.22.2 Product Portfolio
- 16.22.3 Recent Development
- 16.23 Synthaverse S. A.
- 16.23.1 Company Snapshot
- 16.23.2 Revenue Analysis
- 16.23.3 Product Portfolio
- 16.23.4 Recent Developments
- 16.24 Taibang Bio Group Co., Ltd
- 16.24.1 Company Snapshot
- 16.24.2 Product Portfolio
- 16.24.3 Recent Development
- 16.25 Virchow Biotech
- 16.25.1 Company Snapshot
- 16.25.2 Product Portfolio
- 16.25.3 Recent Development
- 17 Questionnaire
- 18 Related Reports
- List Of Tables
- Table 1 Regulatory Framework And Guidelines
- Table 2 Europe Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 3 Europe Immunoglobulins In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 4 Europe Immunoglobulins In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 5 Europe Intravenous Immunoglobulins (Ivigs) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 6 Europe Intramuscular Immunoglobulins (Imig) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 7 Europe Coagulation Factors (For Bleeding Disorders) In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 8 Europe Coagulation Factors In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 9 Europe Factor Ix In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 10 Europe Recombinant Factor Ix (Rfix) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 11 Europe Factor Viii In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 12 Europe Recombinant Factor Viii (Rfviii) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 13 Europe Fibrinogen In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 14 Europe Prothrombin Complex Concentrates (Pccs) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 15 Europe Von Willebrand Factor (Vwf) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 16 Europe Factor Xiii Concentrates In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 17 Europe Factor Xiii Concentrates In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 18 In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 19 Europe Albumin In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 20 Europe Protease Inhibitors (For Genetic Deficiencies)In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 21 Europe Protease Inhibitors (For Genetic Deficiencies) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 22 Europe Alpha 1 Antitrypsin (Aat) (For Aat Deficiency) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 23 Europe C1 Esterase Inhibitor (C1 Inh) (For Hae) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 24 Europe Monoclonal Antibodies (Derived From Plasma Cells )In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 25 Europe Monoclonal Antibodies (Derived From Plasma Cells) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 26 Europe Other Plasma Derived Proteins In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 27 Europe Other Plasma Derived Proteins In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 28 Europe Antithrombin Iii (At Iii) (For Thrombosis Prevention) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 29 Europe Blood Plasma & Plasma Derived Medicinal Products Market, By Application, 2025-2032 (Usd Thousand)
- Table 30 Europe Immunology In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 31 Europe Hematology In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 32 Europe Critical Care In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 33 Europe Neurology In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 34 Europe Pulmonology In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 35 Europe Hematology -oncology In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 36 Europe Rheumatology In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 37 Europe Other Applications In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 38 Europe Blood Plasma & Plasma Derived Medicinal Products Market, By Technology, 2025-2032 (Usd Thousand)
- Table 39 Europe Ion Exchange Chromatography In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 40 Europe Affinity Chromatography In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 41 Europe Cryoprecipitation In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 42 Europe Ultrafiltration In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 43 Europe Microfiltration In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 44 Europe Blood Plasma & Plasma Derived Medicinal Products Market, By Mode, 2025-2032 (Usd Thousand)
- Table 45 Europe Modern In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 46 Europe Traditional Plasma Fractionation In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 47 Europe Blood Plasma & Plasma Derived Medicinal Products Market, By End User, 2025-2032 (Usd Thousand)
- Table 48 Europe Hospitals & Clinics In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 49 Europe Research Labs In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 50 Europe Academic Institutes In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 51 Europe Others Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 52 Europe Blood Plasma & Plasma Derived Medicinal Products Market, By Distribution Channel, 2025-2032 (Usd Thousand)
- Table 53 Europe Direct Tenders In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 54 Europe Third Party Distributors In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 55 Europe Others In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 56 Europe Blood Plasma & Plasma Derived Medicinal Products Market, By Country, 2018-2032 (Usd Thousand)
- Table 57 Europe Blood Plasma & Plasma Derived Medicinal Products Market, By Product, 2018-2032 (Usd Thousand)
- Table 58 Europe Immunoglobulins In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 59 Europe Intravenous Immunoglobulins (Ivigs) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 60 Europe Intramuscular Immunoglobulins (Imig) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 61 Europe Coagulation Factors (For Bleeding Disorders) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 62 Europe Factor Ix Products In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 63 Europe Recombinant Factor Ix (Rfix) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 64 Europe Factor Viii Products In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 65 Europe Recombinant Factor Viii (Rfviii) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 66 Europe Fibrinogen Concentrates In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 67 Europe Prothrombin Complex Concentrates (Pccs) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 68 Europe Von Willebrand Factor (Vwf) Products In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 69 Europe Factor Xiii Concentrates In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 70 Europe Factor Viia In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 71 Europe Albumin (Plasma Volume Expander) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 72 Europe Protease Inhibitors (For Genetic Deficiencies) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 73 Europe Alpha 1 Antitrypsin (Aat) (For Aat Deficiency) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 74 Europe C1 Esterase Inhibitor (C1 Inh) (For Hae) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 75 Europe Monoclonal Antibodies (Derived From Plasma Cells) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 76 Europe Other Plasma Derived Proteins In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 77 Europe Antithrombin Iii (At Iii) (For Thrombosis Prevention) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 78 Europe Blood Plasma & Plasma Derived Medicinal Products Market, By Application, 2018-2032 (Usd Thousand)
- Table 79 Europe Blood Plasma & Plasma Derived Medicinal Products Market, By Processing Technology, 2018-2032 (Usd Thousand)
- Table 80 Europe Blood Plasma & Plasma Derived Medicinal Products Market, By Mode, 2018-2032 (Usd Thousand)
- Table 81 Europe Blood Plasma & Plasma Derived Medicinal Products Market, By End User, 2018-2032 (Usd Thousand)
- Table 82 Europe Blood Plasma & Plasma Derived Medicinal Products Market, By Distribution Channel, 2018-2032 (Usd Thousand)
- Table 83 Germany Blood Plasma & Plasma Derived Medicinal Products Market, By Product, 2018-2032 (Usd Thousand)
- Table 84 Germany Immunoglobulins In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 85 Germany Intravenous Immunoglobulins (Ivigs) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 86 Germany Intramuscular Immunoglobulins (Imig) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 87 Germany Coagulation Factors (For Bleeding Disorders) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 88 Germany Factor Ix Products In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 89 Germany Recombinant Factor Ix (Rfix) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 90 Germany Factor Viii Products In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 91 Germany Recombinant Factor Viii (Rfviii) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 92 Germany Fibrinogen Concentrates In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 93 Germany Prothrombin Complex Concentrates (Pccs) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 94 Germany Von Willebrand Factor (Vwf) Products In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 95 Germany Factor Xiii Concentrates In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 96 Germany Factor Viia In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 97 Germany Albumin (Plasma Volume Expander) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 98 Germany Protease Inhibitors (For Genetic Deficiencies) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 99 Germany Alpha 1 Antitrypsin (Aat) (For Aat Deficiency) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 100 Germany C1 Esterase Inhibitor (C1 Inh) (For Hae) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 101 Germany Monoclonal Antibodies (Derived From Plasma Cells) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 102 Germany Other Plasma Derived Proteins In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 103 Germany Antithrombin Iii (At Iii) (For Thrombosis Prevention) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 104 Germany Blood Plasma & Plasma Derived Medicinal Products Market, By Application, 2018-2032 (Usd Thousand)
- Table 105 Germany Blood Plasma & Plasma Derived Medicinal Products Market, By Processing Technology, 2018-2032 (Usd Thousand)
- Table 106 Germany Blood Plasma & Plasma Derived Medicinal Products Market, By Mode, 2018-2032 (Usd Thousand)
- Table 107 Germany Blood Plasma & Plasma Derived Medicinal Products Market, By End User, 2018-2032 (Usd Thousand)
- Table 108 Germany Blood Plasma & Plasma Derived Medicinal Products Market, By Distribution Channel, 2018-2032 (Usd Thousand)
- Table 109 France Blood Plasma & Plasma Derived Medicinal Products Market, By Product, 2018-2032 (Usd Thousand)
- Table 110 France Immunoglobulins In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 111 France Intravenous Immunoglobulins (Ivigs) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 112 France Intramuscular Immunoglobulins (Imig) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 113 France Coagulation Factors (For Bleeding Disorders) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 114 France Factor Ix Products In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 115 France Recombinant Factor Ix (Rfix) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 116 France Factor Viii Products In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 117 France Recombinant Factor Viii (Rfviii) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 118 France Fibrinogen Concentrates In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 119 France Prothrombin Complex Concentrates (Pccs) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 120 France Von Willebrand Factor (Vwf) Products In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 121 France Factor Xiii Concentrates In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 122 Germany Factor Viia In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 123 France Factor Viia In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 124 France Albumin (Plasma Volume Expander) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 125 France Protease Inhibitors (For Genetic Deficiencies) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 126 France Alpha 1 Antitrypsin (Aat) (For Aat Deficiency) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 127 France C1 Esterase Inhibitor (C1 Inh) (For Hae) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 128 France Monoclonal Antibodies (Derived From Plasma Cells) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 129 France Other Plasma Derived Proteins In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 130 France Antithrombin Iii (At Iii) (For Thrombosis Prevention) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 131 France Blood Plasma & Plasma Derived Medicinal Products Market, By Application, 2018-2032 (Usd Thousand)
- Table 132 France Blood Plasma & Plasma Derived Medicinal Products Market, By Processing Technology, 2018-2032 (Usd Thousand)
- Table 133 France Blood Plasma & Plasma Derived Medicinal Products Market, By Mode, 2018-2032 (Usd Thousand)
- Table 134 France Blood Plasma & Plasma Derived Medicinal Products Market, By End User, 2018-2032 (Usd Thousand)
- Table 135 France Blood Plasma & Plasma Derived Medicinal Products Market, By Distribution Channel, 2018-2032 (Usd Thousand)
- Table 136 U.K. Blood Plasma & Plasma Derived Medicinal Products Market, By Product, 2018-2032 (Usd Thousand)
- Table 137 U.K. Immunoglobulins In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 138 U.K. Intravenous Immunoglobulins (Ivigs) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 139 U.K. Intramuscular Immunoglobulins (Imig) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 140 U.K. Coagulation Factors (For Bleeding Disorders) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 141 U.K. Factor Ix Products In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 142 U.K. Recombinant Factor Ix (Rfix) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 143 U.K. Factor Viii Products In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 144 U.K. Recombinant Factor Viii (Rfviii) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 145 U.K. Fibrinogen Concentrates In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 146 U.K. Prothrombin Complex Concentrates (Pccs) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 147 U.K. Von Willebrand Factor (Vwf) Products In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 148 U.K. Factor Xiii Concentrates In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 149 U.K. Factor Viia In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- List Of Figures
- Figure 1 Europe Blood Plasma & Plasma Derived Medicinal Products Market: Segmentation
- Figure 2 Europe Blood Plasma & Plasma Derived Medicinal Products Market: Data Triangulation
- Figure 3 Europe Blood Plasma & Plasma Derived Medicinal Products Market: Droc Analysis
- Figure 4 Europe Blood Plasma & Plasma Derived Medicinal Products Market: Europe Vs Regional Market Analysis
- Figure 5 Europe Blood Plasma & Plasma Derived Medicinal Products Market: Company Research Analysis
- Figure 6 Europe Blood Plasma & Plasma Derived Medicinal Products Market: Multivariate Modelling
- Figure 7 Europe Blood Plasma & Plasma Derived Medicinal Products Market: Interview Demographics
- Figure 8 Europe Blood Plasma & Plasma Derived Medicinal Products Market: Dbmr Market Position Grid
- Figure 9 Europe Blood Plasma & Plasma Derived Medicinal Products Market: Market End User Coverage Grid
- Figure 10 Europe Blood Plasma & Plasma Derived Medicinal Products Market: Vendor Share Analysis
- Figure 11 Europe Blood Plasma & Plasma Derived Medicinal Products Market: Segmentation
- Figure 12 Europe Blood Plasma & Plasma Derived Medicinal Products Market, By Product (2024)
- Figure 13 Europe Blood Plasma & Plasma Derived Medicinal Products Market: Executive Summary
- Figure 14 Strategic Decisions
- Figure 15 Rising Prevalence Of Rare And Chronic Diseases Is Expected To Drive The Europe Blood Plasma & Plasma Derived Medicinal Products Market In The Forecast Period Of 2025 To 2032
- Figur
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
